Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Journal of Oncology Practice|September 3, 2011
A model for rural oncologyLaurence J Heifetz, Scott D Christensen, Ralph W Devere-White, et al.
Urologic Oncology|June 18, 2003
Is bladder biopsy necessary at three or six months post BCG therapy?Ralph A Highshaw, Stacy T Tanaka, Christopher P Evans, et al.
Urologic Oncology|May 6, 2009
MicroRNAs and their potential for translation in prostate cancerRalph W DeVere White, Ruth L Vinall, Clifford G Tepper, et al.
BJU International|October 24, 2009
The role of surveillance in the treatment of patients with muscle-invasive bladder cancer after chemotherapyNicholas J Hellenthal, Michelle L Ramirez, Christopher P Evans, et al.
Cancer|July 31, 2008
Agent Orange exposure, Vietnam War veterans, and the risk of prostate cancerKarim Chamie, Ralph W DeVere White, Dennis Lee, et al.
Urology|June 19, 2007
Cost-benefit and outcome analysis: effect of prostate biopsy undergradingAngelo J Cambio, Lars M Ellison, Karim Chamie, et al.
Urology|October 19, 2002
Effects of a mushroom mycelium extract on the treatment of prostate cancerRalph W deVere White, Robert M Hackman, Stephanie E Soares, et al.
International Journal of Cancer|June 25, 2011
MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway statusRuth L Vinall, Alexandra Z Ripoll, Sisi Wang, et al.
The Journal of Urology|April 18, 2009
Trends in pelvic lymphadenectomy at the time of radical cystectomy: 1988 to 2004Nicholas J Hellenthal, Michelle L Ramírez, Christopher P Evans, et al.
Urology|September 8, 2004
Analysis of treatment for small cell cancer of the bladder and report of three casesEdward Karpman, Zelanna Goldberg, Amir Saffarian, et al.
Pageof 6